Alessandra Bertola
About
In The Last Decade
Alessandra Bertola
13 papers receiving 550 citations
Peers
Comparison fields: 5 of 48
- Hematology 520
- Molecular Biology 369
- Oncology 330
- Genetics 63
- Neurology 25
Countries citing papers authored by Alessandra Bertola
This map shows the geographic impact of Alessandra Bertola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Bertola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Bertola more than expected).
Fields of papers citing papers by Alessandra Bertola
This network shows the impact of papers produced by Alessandra Bertola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Bertola. The network helps show where Alessandra Bertola may publish in the future.
Co-authorship network of co-authors of Alessandra Bertola
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Bertola. A scholar is included among the top collaborators of Alessandra Bertola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Bertola. Alessandra Bertola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 60 | |
| 2 | 25 | |
| 3 | 104 | |
| 4 | 48 | |
| 5 | 26 | |
| 6 | 6 | |
| 7 | TWO DOSE-INTENIVE MELPHALAN REGIMENS (100 MG/M2 VERSUS 200 MG/M2) IN MULTIPLE MYELOMA PATIENTS | 12 |
| 8 | 44 | |
| 9 | 23 | |
| 10 | Low-dose thalidomide and dexamethasone improves survival in advanced multiple myeloma | 1 |
| 11 | Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma. | 62 |
| 12 | Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma. | 157 |
| 13 | IN MYELOMA PATIENTS TREATED WITH MELPHALAN 100mg/m2 OR MELPHALAN 200mg/m2 OUTCOME IS NOT SIGNIFICANTLY DIFFERENT | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.